ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985

DePinho’s Letter to the AAUP

May 30, 2014

New CCSP And CCRU Awards Applications Under Review

January 17, 1986

Group Chairs Seek Role Running NCTN

September 12, 2014

ASCO, FDA Website To Help Demystify Expanded Access

June 25, 2010